Smart Polymer-Derived Injectable Hydrogels: Current Status and Future Perspectives
Maity S., Mahata K., Meshram B., Banerjee S.
Narrative Review, published in ACS Polym Au (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- ACS Polym Au (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41657385
- PMCID
- PMC12874161
- DOI
- 10.1021/acspolymersau.5c00053
- Citations
- 11
Abstract (original English)
Because of their tissue-conforming qualities, in situ gelation, and less invasive distribution, injectable hydrogels (IHs) have become a revolutionary class of soft materials with enormous potential in biomedical applications. The ability of stimuli-responsive polymer-derived smart injectable hydrogels (SIHs) to react dynamically to external stimuli like temperature, redox potential, pH, or enzyme activity has drawn more attention than any other. This responsiveness enables precise spatiotemporal control over therapeutic delivery, tissue regeneration, and self-healing capabilities. Recent advances in cross-linking strategies, including reversible covalent and supramolecular interactions, have expanded the design space for SIHs, enhancing their adaptability to dynamic physiological environments. With an emphasis on structure-property connections, rheological behavior, dynamic cross-linking mechanisms, and stimuli-triggered transitions, we provide a thorough summary of the basic ideas guiding the injectability and functioning of SIHs in this review. From biosensing and regenerative medicine to tissue engineering and cancer treatment, we critically analyze the most recent advancements in their biomedical applications. Despite substantial progress, challenges such as mechanical fragility, limited biodegradability, cytotoxicity concerns, and scalability remain significant barriers t
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.